2015-10-23 WAYNE, Pa., Oct. 23, 2015 /PRNewswire/ --Safeguard Scientifics, Inc. (NYSE: SFE) today announced third quarter 2015 financial results. Safeguard's partner companies achieved significant developmental milestones and recorded continued aggregate revenue growth. For the three months ended September 30, 2015, Safeguard partner company aggregate revenue was $114.6 million, up 33% from $86.3 million for the same quarter of 2014. For the nine months ended September 30, 2015, partner company aggregate revenue was $333.1 million, up 29% from $258.2 million for the same period in 2014. "While public markets suffered substantial volatility during the third quarter, Safeguard's partner companies continued to grow revenue on an aggregate basis and achieved significant developmental milestones," said Safeguard President and CEO Stephen T. Zarrilli. "Safeguard remains on track to realize continued growth in partner company aggregate revenue; to increase the total number of our partner companies to approximately 30; to deploy $35 million to $50 million in new partner companies and $30 million to $50 million in follow-on funding for current partner companies; and to execute a minimum of two profitable exits with a minimum aggregate cash value of $50 million. We are confident that our near-term successes will sustain our long-term commitment to drive significant increases in Safeguard's assets under management." For the three months ended September 30, 2015, Safeguard's net loss was $11.6 million, or $0.56 per share, compared with net loss of $14.0 million, or $0.68 per share, for the same quarter of 2014. For the nine months ended September 30, 2015, Safeguard's net loss was $45.3 million, or $2.17 per share, compared with net income of $10.0 million, or $0.47 per share, in the same period last year. At September 30, 2015, Safeguard's roster of 27 partner companies was comprised of 11 healthcare and 16 technology companies. "The cost of our interests in these companies totaled $278.9 million," said Jeffrey B. McGroarty, Safeguard Senior Vice President and CFO. "Our net cash, cash equivalents and marketable securities at quarter-end totaled $52.8 million, after subtracting the total carrying value of debt outstanding of $51.4 million. During the third quarter of 2015, we deployed $11.5 million in follow-on funding to two existing partner companies. We also received initial proceeds of $7.8 million from the previously announced sale of Quantia, and we realized an aggregate of $5.9 million in proceeds from milestone payments and escrow from prior years' exits." During the third quarter, Safeguard repurchased $1.7 million of its common stock in open market transactionsrepresenting 99,100 shares with an average price of $17.61 per shareunder an ongoing $25 million share repurchase authorization. Additional repurchases may be made in open market or privately negotiated transactions in compliance with Securities and Exchange Commission requirements and based on market conditions. At September 30, 2015, Safeguard shares outstanding totaled 20.7 million. Significant accomplishments by Safeguard's partner companies during the third quarter include: AGGREGATE PARTNER COMPANY REVENUE For 2015, partner company aggregate revenue is projected to be between $430 million and $450 million, which includes revenue for all partner companies in which Safeguard had an interest at January 1, 2015, but excludes DriveFactor, which was sold in April 2015, and Quantia, which was sold in July 2015. Aggregate revenue for the same partner companies was $359 million for 2014 and $290 million for 2013. Aggregate revenue for all years reflects revenue on a net basis. Revenue data for certain partner companies pertains to periods prior to Safeguard's involvement with those companies and are based solely on information provided to Safeguard by those companies.  PARTNER COMPANY HIGHLIGHTS The following partner company highlights represent information as of September 30, 2015.  Partner Company Revenue Stages Development Stage Initial Revenue Stage Expansion Stage High Traction Stage 